We are live on ! Find out more
ADXS

Advaxis Inc

Delisted

ADXS was delisted on the 22nd of December, 2021.

98 hedge funds and large institutions have $162M invested in Advaxis Inc in 2016 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 37 increasing their positions, 20 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

85% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 20

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

7% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 15

2% less funds holding

Funds holding: 10098 (-2)

18% less call options, than puts

Call options by funds: $5.51M | Put options by funds: $6.73M

35% less capital invested

Capital invested by funds: $247M → $162M (-$85.4M)

Holders
98
Holders Change
-2
Holders Change %
-2%
% of All Funds
2.45%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
14
Increased
37
Reduced
20
Closed
15
Calls
$5.51M
Puts
$6.73M
Net Calls
-$1.22M
Net Calls Change
-$2.35M
Name Holding Trade Value Shares
Change
Change in
Stake
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$42.5M
Fidelity Investments
2
Fidelity Investments
Massachusetts
$29.4M -$249K -1,846 -0.7%
Vanguard Group
3
Vanguard Group
Pennsylvania
$10.9M +$458K +3,396 +3%
BC
4
Broadfin Capital
New York
$10.9M -$409K -3,028 -3%
BFA
5
BlackRock Fund Advisors
California
$8.25M +$1.45M +10,738 +16%
BIT
6
BlackRock Institutional Trust
California
$6.76M +$105K +778 +1%
SAM
7
Sectoral Asset Management
Quebec, Canada
$4.94M +$2.28M +16,894 +58%
Marshall Wace
8
Marshall Wace
United Kingdom
$4.86M +$1.07M +7,941 +21%
State Street
9
State Street
Massachusetts
$4.45M +$903K +6,689 +19%
SCM
10
Sarissa Capital Management
Connecticut
$3.58M -$900K -6,667 -17%
Northern Trust
11
Northern Trust
Illinois
$3.11M +$155K +1,149 +4%
CS
12
Credit Suisse
Switzerland
$2.16M +$1.86M +13,800 +219%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$1.91M +$70.6K +523 +3%
KCM
14
Knoll Capital Management
Florida
$1.61M -$450K -3,333 -18%
Citadel Advisors
15
Citadel Advisors
Florida
$1.47M +$587K +4,352 +47%
NC
16
Nexthera Capital
New York
$1.43M
Morgan Stanley
17
Morgan Stanley
New York
$1.36M +$796K +5,896 +88%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$1.29M -$363K -2,691 -18%
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
$1.29M +$1.23M +9,130 +317%
DCM
20
DAFNA Capital Management
California
$1.25M +$1.57M +11,667 New
Allianz Asset Management
21
Allianz Asset Management
Germany
$1.05M -$223K -1,652 -14%
BIM
22
BlackRock Investment Management
Delaware
$1.02M +$2.16K +16 +0.2%
TCM
23
Tanaka Capital Management
New York
$995K +$318K +2,355 +34%
TCIM
24
TIAA CREF Investment Management
New York
$922K +$222K +1,647 +24%
Thrivent Financial for Lutherans
25
Thrivent Financial for Lutherans
Minnesota
$901K

ADXS Hedge Fund Activity: Q4 2016 in Review

98 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Advaxis Inc (ADXS) for Q4 2016, worth a combined $162M — down 35% from $247M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of ADXS and 14 opened new positions — a net loss of 1 holder — while 20 trimmed existing stakes and 37 added.

The largest buyer was Sectoral Asset Management, adding an estimated $2.28M. The largest seller was Cormorant Asset Management, exiting entirely with an estimated $9.85M sold.

  • 98 institutional investors held Advaxis Inc (ADXS) as of Q4 2016, down from 100 in Q3 2016.
  • Funds reported $162M of Advaxis Inc stock for Q4 2016, down 35% quarter-over-quarter.
  • 14 funds opened new Advaxis Inc positions in Q4 2016 and 15 closed out, a net change of -1 holder.
  • The largest Advaxis Inc buyer in Q4 2016 was Sectoral Asset Management, an estimated $2.28M added.
  • The largest Advaxis Inc seller in Q4 2016 was Cormorant Asset Management, an estimated $9.85M sold.

Based on aggregated 13F filings for Q4 2016.